HomeInsightsPE

Divis Laboratories Ltd PE Ratio

Divis Laboratories Ltd PE Ratio

stocks purchased

₹ 13.8 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

22.5 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 07, 2024

Image

Divis Laboratories Ltd

NSE: DIVISLAB

PE

88.6

Last updated on: Dec 07, 2024

Key Highlights

  • The P/E Ratio of Divis Laboratories Ltd is 88.6 as of 07 Dec 9.00 AM .
  • The P/E Ratio of Divis Laboratories Ltd changed from 33.4 on March 2019 to 56.9 on March 2024 . This represents a CAGR of 9.29% over 6 years.
  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6130 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Divis Laboratories Ltd

No data available

Company Fundamentals for Divis Laboratories Ltd

No data available

Image

Divis Laboratories Ltd

NSE: DIVISLAB

Share Price

₹ 6130.1

34.10 (0.56%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Divis Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Divis Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 20246130.1
05 Dec 20246096
04 Dec 20246257.95
03 Dec 20246210.35
02 Dec 20246250.2
29 Nov 20246171.05
28 Nov 20245953.6
27 Nov 20246000.95
26 Nov 20246071.65
25 Nov 20246140.7

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Divis Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Divis Laboratories Ltd881,62,734
Sun Pharmaceuticals Industries Ltd384,33,032
Cipla Ltd251,19,333
Torrent Pharmaceuticals Ltd641,12,773
Dr Reddys Laboratories Ltd191,04,603
Mankind Pharma Ltd491,03,575

Key Valuation Metric of Divis Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Divis Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Divis Laboratories Ltd

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd rises for third straight session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

2024-08-21 00:00:00

News

Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr

Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended...

Read more

2024-08-03 00:00:00

News

Divi's Laboratories consolidated net profit rises 20.79% in the June 2024 quarter

Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June...

Read more

2024-08-03 00:00:00

News

Divis Laboratories Ltd up for third straight session

Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at ...

Read more

2024-09-05 00:00:00

News

Divis Laboratories Ltd spurts 0.46%, rises for fifth straight session

Divis Laboratories Ltd gained for a fifth straight session today. The stock is quoting at ...

Read more

2024-09-09 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Divis Laboratories Ltd

What is the current PE Ratio of Divis Laboratories Ltd?

The Current PE Ratio of Divis Laboratories Ltd is 88.64 as on 7 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 7 Dec 2024.

What was the PE Ratio of Divis Laboratories Ltd last year?

The PE Ratio of Divis Laboratories Ltd was 41.05 last year, now the PE ratio is 88.64, showing a year-on-year growth of 115.9%.

What does the PE Ratio of Divis Laboratories Ltd indicate about its stock?

The PE Ratio of Divis Laboratories Ltd is 88.64. This ratio indicates that investors are willing to pay 88.64 times the earnings per share for each share of Divis Laboratories Ltd.

What is the PE Ratio Growth of Divis Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Divis Laboratories Ltd grew by 115.9% whereas, the EPS ratio grew by 18.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions